KR980002033A - 트리아졸 유도체 또는 그 염 - Google Patents
트리아졸 유도체 또는 그 염 Download PDFInfo
- Publication number
- KR980002033A KR980002033A KR1019970025406A KR19970025406A KR980002033A KR 980002033 A KR980002033 A KR 980002033A KR 1019970025406 A KR1019970025406 A KR 1019970025406A KR 19970025406 A KR19970025406 A KR 19970025406A KR 980002033 A KR980002033 A KR 980002033A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- medicament
- salts
- group
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 하기 화학식(1)의 트리아졸 유도체 또는 그 염 및 이를 유효성분으로 함유하는 의약에 관한 것이다 :
상기 식에서, R은 수소원자, 알킬기, 아르알킬기 또는 아실기를 나타내고, n은 0~2를 나타내고, m은 1~5를 나타낸다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 하기 화학식(1)의 트리아졸 유도체 또는 그 염 :상기 식에서, R은 수소원자, 알킬기, 아르알킬기 또는 아실기를 나타내고, n은 0~2를 나타내고, m은 1~5를 나타낸다.
- 하기 화학식(2)의 화합물 :상기 식에서, R은 수소원자, 알킬기, 아르알킬기 또는 아실기를 나타내고, m은 1~5를 나타낸다.
- 제1항에 청구된 트리아졸 유도체 또는 그 염을 유효성분으로 함유하는 의약.
- 제3항에 있어서, 항진균제인 것을 특징으로 하는 의약.
- 제1항에 청구된 트리아 유도체 또는 그 염 및 약학적으로 허용 가능한 담체를 함유하는 약학 조성물.
- 제5항에 있어서, 항진균 조성물인 것을 특징으로 하는 약학 조성물.
- 제1항에 청구된 트리아졸 유도체 또는 그 염의 의약으로서의 용도.
- 제7항에 있어서, 의약이 항진균제인 것을 특징으로 하는 용도.
- 제1항에 청구된 트리아졸 유도체 또는 그 염의 유효량을 환자에게 투여하는 것을 특징으로 하는 진균증의 예방 또는 치료방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP161760/1996 | 1996-06-21 | ||
JP161760 | 1996-06-21 | ||
JP16176096 | 1996-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR980002033A true KR980002033A (ko) | 1998-03-30 |
KR100257549B1 KR100257549B1 (ko) | 2000-07-01 |
Family
ID=15741381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970025406A KR100257549B1 (ko) | 1996-06-21 | 1997-06-18 | 트리아졸 유도체 또는 그 염 |
Country Status (7)
Country | Link |
---|---|
US (2) | US5939448A (ko) |
EP (1) | EP0814079B1 (ko) |
KR (1) | KR100257549B1 (ko) |
CN (1) | CN1172108A (ko) |
CA (1) | CA2207484A1 (ko) |
DE (1) | DE69704396T2 (ko) |
ES (1) | ES2157498T3 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW438784B (en) * | 1997-08-29 | 2001-06-07 | Ssp Co Ltd | Triazole derivative or salt thereof and pharmaceutical composition for treating mycosis containing the same |
JP3638438B2 (ja) * | 1997-12-26 | 2005-04-13 | エスエス製薬株式会社 | トリアゾール誘導体またはその塩、その製造方法及び当該化合物を有効成分とする医薬 |
EP0933368A1 (en) | 1998-02-02 | 1999-08-04 | SSP Co., Ltd. | Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (antimycotic) |
JP2000226368A (ja) | 1999-02-04 | 2000-08-15 | Ss Pharmaceut Co Ltd | ジフルオロアセトフェノン誘導体の製造法 |
KR20010050557A (ko) | 1999-09-29 | 2001-06-15 | 타이도 나오카타 | 아졸 유도체 또는 그의 염 |
EP2894981B1 (en) * | 2012-09-12 | 2019-12-04 | Dow AgroSciences LLC | Metalloenzyme inhibitor compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BG48681A3 (en) * | 1982-12-14 | 1991-04-15 | Ciba Geigy Ag | Fungicide means |
KR930004193B1 (ko) * | 1984-10-02 | 1993-05-21 | 스미또모 세이야꾸 가부시끼가이샤 | N-치환된 트리아졸 유도체의 제조방법 |
US4999429A (en) * | 1989-01-09 | 1991-03-12 | Ethyl Corporation | Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives |
JPH0383973A (ja) * | 1989-08-28 | 1991-04-09 | Sumitomo Pharmaceut Co Ltd | エポキシ体のスレオ選択的製造法 |
CA2031892C (en) * | 1989-12-25 | 2000-08-01 | Minoru Tokizawa | Triazole derivatives |
JP3471831B2 (ja) * | 1991-12-09 | 2003-12-02 | 富山化学工業株式会社 | 新規なトリアゾール誘導体およびその塩 |
-
1997
- 1997-06-10 US US08/872,159 patent/US5939448A/en not_active Expired - Fee Related
- 1997-06-11 CA CA002207484A patent/CA2207484A1/en not_active Abandoned
- 1997-06-18 DE DE69704396T patent/DE69704396T2/de not_active Expired - Fee Related
- 1997-06-18 ES ES97109942T patent/ES2157498T3/es not_active Expired - Lifetime
- 1997-06-18 KR KR1019970025406A patent/KR100257549B1/ko not_active IP Right Cessation
- 1997-06-18 EP EP97109942A patent/EP0814079B1/en not_active Expired - Lifetime
- 1997-06-20 CN CN97113904A patent/CN1172108A/zh active Pending
-
1999
- 1999-06-08 US US09/327,516 patent/US6063945A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2207484A1 (en) | 1997-12-21 |
KR100257549B1 (ko) | 2000-07-01 |
EP0814079A1 (en) | 1997-12-29 |
DE69704396T2 (de) | 2001-07-05 |
DE69704396D1 (de) | 2001-05-03 |
ES2157498T3 (es) | 2001-08-16 |
CN1172108A (zh) | 1998-02-04 |
US5939448A (en) | 1999-08-17 |
EP0814079B1 (en) | 2001-03-28 |
US6063945A (en) | 2000-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU13695A (sh) | Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije | |
NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
NO942155D0 (no) | Legemiddelformuleringer for parenteral anvendelse | |
KR950007859A (ko) | 경구 투여용 라파마이신 제형 | |
KR970706021A (ko) | N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS) | |
KR950016732A (ko) | 피부 및 질의 위축 억제방법 | |
KR890003382A (ko) | 항 비루스성 화합물 | |
KR950016726A (ko) | 기능부전성 자궁 출혈을 억제하는 방법 | |
KR950016723A (ko) | 자가면역 질병의 억제 방법 | |
DE68902301D1 (de) | Diarylverbindungen als antiatherosklerotische mittel. | |
KR930703292A (ko) | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 | |
KR880007073A (ko) | 의 약 품 | |
KR880007074A (ko) | 의약품 | |
KR950703527A (ko) | 프로스타글란딘 유도체 | |
KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
KR910004191A (ko) | 신질환치료제 | |
KR950016760A (ko) | 치질 치료제 | |
TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
KR980002033A (ko) | 트리아졸 유도체 또는 그 염 | |
MX9203361A (es) | Composiciones farmaceuticas que contienen cloruro de galio. | |
TR200103144T2 (tr) | Yeni bileşikler | |
KR950008502A (ko) | 3-또는4-클리코실옥시벤조피란 유도체 및 활성 성분으로서 이를 함유하는 알러지치료제 | |
KR960702458A (ko) | 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제 | |
KR950032264A (ko) | 7-글리코실옥시벤조피란 유도체 및 이를 활성 성분으로서 함유하는 항알레르기제 | |
NO950177D0 (no) | Farmakologisk aktive erivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030221 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |